Market by Type, Prescription, Therapeutic, Application, End-user, and Country | Forecast 2021-2028
As per Triton’s research report, the nasal spray market in Europe is
expected to thrive at a CAGR of 8.35% during the estimated years from 2021 to
2028.
Report scope can be customized per your requirements. Request For Customization
The countries sifted in this market include:
• The UK
• Spain
• Germany
• Italy
• France
• Russia
• Rest of Europe
In the region, there is a high prevalence of nasal polyps and chronic
rhinosinusitis. Further, the surge in the aging population has increased the
burden of respiratory diseases to a large extent. Here, some of the major
respiratory conditions include asthma, chronic obstructive pulmonary disease,
respiratory allergies, and pulmonary hypertension. Besides, lung cancer has
become a leading cause of death in the region. This surge in respiratory conditions
has enhanced the demand for nasal sprays, which drives the development of the
nasal spray market within Europe.
Given the UK market, respiratory diseases are the third major cause of
death, including lung cancer, asthma, pneumonia, and others. Besides this,
allergic rhinitis is highly prevalent, affecting 20% of the country’s
population. Additionally, air pollution has become a significant problem
leading to various health concerns, influencing the adoption of nasal sprays to
treat various conditions. Hence, as mentioned above, the rise in respiratory
diseases will ultimately augment the growth of the nasal spray market
throughout the United Kingdom.
GlaxoSmithKline is a healthcare company engaged in researching,
developing, and manufacturing pharmaceutical medicines, vaccines, and consumer
healthcare products. Additionally, the company combines science and consumer
insights to create healthcare brands for oral health, pain, cold, digestive
health, and others. Its product line includes Otrivin Adult 0.1% Nasal Spray
that offers effective relief from nasal congestion caused due to colds and
allergies. The company is headquartered in the United Kingdom.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
NASAL SPRAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON NASAL SPRAY MARKET
2.2. KEY
INSIGHTS
2.2.1. ALLERGY
TREATMENTS WITH NASAL SPRAYS
2.2.2. UTILIZING
NASAL SPRAY FOR DIABETES
2.2.3. ENDOMETRIOSIS
TREATMENT WITH NASAL SPRAYS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. CONTRACTS
& AGREEMENTS
2.6.3. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. EMERGING
INTRANASAL VACCINES FOR COVID-19
2.7.2. INCREASING
ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION
2.7.3. GROWING
USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES
2.8. MARKET
CHALLENGES
2.8.1. COMPLICATIONS
DUE TO EXCESS USE OF NASAL SPRAYS
2.9. MARKET
OPPORTUNITIES
2.9.1. APPLICATION
OF NASAL SPRAYS IN TREATING DEPRESSION
2.9.2. USING
INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS
2.9.3. EMPLOYING
NASAL SPRAY AS A VACCINE
3. EUROPE
NASAL SPRAY MARKET OUTLOOK - BY TYPE
3.1. DECONGESTION
NASAL SPRAY
3.2. STEROID
NASAL SPRAY
3.3. SALTWATER
SOLUTION/SALINE NASAL SPRAY
4. EUROPE
NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION
4.1. OVER-THE-COUNTER
4.2. PRESCRIBED
5. EUROPE
NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC
5.1. ANTIHISTAMINE
5.2. NASAL
STEROIDS
5.3. ANTICHOLINERGIC
5.4. MAST
CELL INHIBITOR
6. EUROPE
NASAL SPRAY MARKET OUTLOOK - BY APPLICATION
6.1. NASAL
CONGESTION
6.2. ALLERGIC
AND NON-ALLERGIC RHINITIS
6.3. VACCINATION
6.4. CNS
DISORDERS
6.5. OTHER
APPLICATIONS
7. EUROPE
NASAL SPRAY MARKET OUTLOOK - BY END-USER
7.1. HOME
CARE SETTING
7.2. ASC/CLINICS
7.3. PHARMACY
7.4. HOSPITAL
7.5. OTHER
END-USERS
8. EUROPE
NASAL SPRAY MARKET – REGIONAL OUTLOOK
8.1. UNITED
KINGDOM
8.2. GERMANY
8.3. FRANCE
8.4. SPAIN
8.5. ITALY
8.6. RUSSIA
8.7. REST
OF EUROPE
9. COMPETITIVE
LANDSCAPE
9.1. AKORN
9.2. ALLERGAN
9.3. APOTEX
INC
9.4. BHARAT
BIOTECH
9.5. CATALENT
INC
9.6. CIPLA
LIMITED
9.7. GLAXOSMITHKLINE
9.8. JOHNSON
AND JOHNSON
9.9. NOVARTIS
INTERNATIONAL AG
9.10. PFIZER
INC
9.11. PROCTOR
AND GAMBLE CO
9.12. SANOTIZE
RESEARCH AND DEVELOPMENT
9.13. SUN
PHARMACEUTICALS INDUSTRIES LTD
9.14. TEVA
PHARMACEUTICAL INDUSTRIES LTD
9.15. VIATRIS
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE NASAL SPRAY
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: EUROPE NASAL SPRAY
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 4: EUROPE NASAL SPRAY
MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)
TABLE 5: EUROPE NASAL SPRAY
MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE NASAL SPRAY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 7: EUROPE NASAL SPRAY
MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE NASAL SPRAY
MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: EUROPE NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)
FIGURE
3: EUROPE NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $
MILLION)
FIGURE
4: EUROPE NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)
FIGURE
5: EUROPE NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY,
2021-2028 (IN $ MILLION)
FIGURE
6: EUROPE NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)
FIGURE
7: EUROPE NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)
FIGURE
8: EUROPE NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)
FIGURE
9: EUROPE NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)
FIGURE
10: EUROPE NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)
FIGURE
11: EUROPE NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)
FIGURE
12: EUROPE NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)
FIGURE
13: EUROPE NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)
FIGURE
14: EUROPE NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE
15: EUROPE NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)
FIGURE
16: EUROPE NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028
(IN $ MILLION)
FIGURE
17: EUROPE NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)
FIGURE
18: EUROPE NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)
FIGURE
19: EUROPE NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE
20: EUROPE NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)
FIGURE
21: EUROPE NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)
FIGURE
22: EUROPE NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)
FIGURE
23: EUROPE NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)
FIGURE
24: EUROPE NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)
FIGURE
25: EUROPE NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE
26: EUROPE NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE
27: UNITED KINGDOM NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
28: GERMANY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
29: FRANCE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
30: SPAIN NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
31: ITALY NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
32: RUSSIA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)
FIGURE
33: REST OF EUROPE NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)